How it works
How Much Does CyberKnife for brain tumor Cost in Turkey in AUD?
CyberKnife for brain tumor in Turkey typically costs from AUD $7,300 to AUD $9,100. The final price depends on the tumor size, number of radiation fractions required, and the specific clinic technology used. Most Turkish oncology centers include initial MRI diagnostics, radiation planning, and airport transfers in their clinical service fee.
- Number of sessions: Cost directly correlates with whether the tumor requires a single dose or five.
- Medical hub: Prices in Istanbul typically run 15–20% higher than clinics in regional cities.
- Hospital tier: Premium university-affiliated hospitals often charge more than smaller specialised radiation centers.
- Combined treatment: Adding follow-up immunotherapy or chemotherapy significantly increases the total treatment budget.
Bookimed Expert Insight: Choosing a center with Johns Hopkins affiliation, like Anadolu Medical Center, provides Western-standard protocols at Turkish rates. Some clinics, including Medipol Mega University Hospital, offer both CyberKnife and Gamma Knife. This ensures specialists select the most efficient technology for your specific tumor shape. Expert doctors like Professor Banu Atalar, with Stanford training, specialise in these precise treatments for international patients.
| Turkey | Thailand | |
|---|---|---|
| CyberKnife for brain tumor | from AUD $7,300 | ≈ AUD $14,300 |
Best CyberKnife for brain tumor Clinics in Turkey for Australians: 19 Verified Options and AUD Prices
Memorial Ataşehir Hospital
Zafer Orkun Toktas


Hisar Hospital Intercontinental
Mustafa Solak







Memorial Göztepe Hospital
Medical Park Göztepe Hospital Complex
Turker Kilic






Memorial Ankara Hospital
CyberKnife for brain tumor Overview in Turkey
- CyberKnife - from AUD $5,287This therapy is a non-invasive option using precise radiation for treating cancerous and non-cancerous tumors.
- CyberKnife for brain tumor - from AUD $7,250This therapy targets brain tumors with high-dose radiation, sparing healthy tissue, offering less pain and recovery time.
- CyberKnife for prostate cancer - from AUD $9,063The procedure uses precise radiation to destroy prostate cancer, improving survival rates with minimal side effects.
- CyberKnife for lung cancer - from AUD $9,063This therapy uses targeted radiation to destroy lung cancer cells without surgery with minimal side-effects.
- Bookimed deposit: $200 or €200.
- Clinic deposit: Pay a set percentage in advance.
Our Trusted Doctors for Australian Patients
View all Doctors
Banu Atalar
Specializes in CyberKnife for brain tumors with a fellowship in Stereotactic Radiosurgery from Stanford University. Leads at Anadolu Medical Center's Radiation Oncology Department.
- Board-certified in Radiation Oncology since 2004
- Honored with IASLC International Mentorship Award (2018)
- Published 72 international peer-reviewed papers
- President of Turkish Society for Radiation Oncology
- Expert in MR-Guided Adaptive SRS

Mehmet Tonge
Dr. Mehmet Tonge specializes in Stereotactic & Functional Neurosurgery, with 32 publications and 92 presentations on advanced techniques like Gamma Knife Radiosurgery.
- Board member of Turkish Neurosurgical Society's Stereotactic & Functional Neurosurgery Section
- Trained at Zurich University Hospital in microneurosurgery and interventional neuroradiology
- Member of World and European Stereotactic & Functional Neurosurgery Societies
- Assistant Professor at Istanbul Medipol University's Gamma Knife Center

Hasan Ozgur Ozdemir
Prof. Dr. Hasan Özgür Özdemir specializes in brain tumor surgery and CyberKnife procedures at Medical Park Antalya Hospital Complex.
- Over 24 years of neurosurgery experience
- Expert in endoscopic brain surgery techniques
- 1st place in Turkish Neurosurgical Society Proficiency Exam
- Member of Turkish Neurosurgical Society

Mehmet Osman Akcakaya
Associate Professor at Florence Nightingale Hospitals with a fellowship in Stereotactic and Functional Neurosurgery from Hannover Medical School.
- Specializes in neurosurgery with a focus on brain tumors
- Trained in microsurgery of peripheral nerves and brachial plexus in Tel Aviv
- Over 20 years of experience in neurosurgery
- Works at Gayrettepe Florence Nightingale Hospital
Video Stories from Bookimed Patients
Reviews about Bookimed: Discover Patients' Insights
All reviewsShare this content
Anna Leonova
FAQ about CyberKnife for brain tumor in Turkey
What is the success rate of CyberKnife for brain tumours in Turkey?
For local tumour control, CyberKnife success rates for brain tumours in Turkey are typically 83% to 95%. Specialised oncology centres report up to 99% success in complex cases. This non-invasive radiosurgery effectively halts tumour growth. It spares healthy brain tissue with sub-millimetre precision.
- Tumour stabilisation: Specialists achieve 90–95% success in stopping the growth of various brain tumours.
- Metastatic control: Efficacy for controlling brain metastases is approximately 85% after two years.
- Symptom relief: Over 92% of patients report significant reduction in symptoms following the procedure.
- Survival rates: Certain tumour types show a 96.8% one-year survival rate after treatment.
Bookimed Expert Insight: CyberKnife is highly effective, but Turkish professors often recommend Gamma Knife for smaller, deep-seated brain tumours. Prof. Banu Atalar at Anadolu Medical Center specialises in these stereotactic decisions. Patients should confirm which technology is used. Gamma Knife remains the gold standard for certain cranial cases.
Patient Consensus: Patients in Turkey describe the treatment as smooth and efficient. Many are relieved that tumours shrank significantly within months of the final session.
Is CyberKnife treatment for brain tumours painful?
CyberKnife treatment for brain tumours is a painless, non-invasive alternative to surgery. This robotic system delivers high-dose radiation without incisions or anaesthesia. Most patients feel no sensation during the 30 to 90-minute session. They return to work immediately after leaving the clinic.
- No surgical pain: Treatment uses radiation beams rather than scalpels for tumour destruction.
- Mask-based fixation: Soft mesh masks replace invasive metal head frames for patient comfort.
- Zero anaesthesia: Patients remain fully awake and relaxed during the entire outpatient procedure.
- No recovery time: Most people resume normal activities without lingering fatigue or nausea.
Bookimed Expert Insight: Turkish centres like Anadolu Medical Center frequently combine CyberKnife with neuronavigation accurate to 1 mm. This level of precision protects healthy brain tissue more effectively than older systems. Clinicians like Prof. Banu Atalar, who trained at Stanford, now perform these sessions. Data shows the cost is about 86% less than Australian private hospital rates.
Patient Consensus: The experience in Turkey is relaxing. Many patients listen to music or rest during the session. People describe the process as dull or boring rather than scary. They also appreciate the friendly staff.
What types of brain tumours can be treated with CyberKnife in Turkey?
Neuro-oncologists in Turkey use CyberKnife to treat malignant and benign brain tumours with robotic precision. This non-invasive system targets brain metastases, meningiomas, acoustic neuromas, and pituitary adenomas. It delivers high-dose radiation that spares healthy tissue. Specialists also use it for vascular malformations and trigeminal neuralgia.
- Malignant tumours: Treats brain metastases from lung, breast, or melanoma and manages glioblastoma.
- Benign mass types: Effectively shrinks meningiomas, acoustic neuromas, and pituitary adenomas without open theatre surgery.
- Vascular conditions: Targets arteriovenous malformations (AVMs) by causing abnormal vessels to gradually close.
- Precision tracking: Uses S7 or M6 systems to adjust for sub-millimetre tumour movement automatically.
Bookimed Expert Insight: Turkish centres like Anadolu Medical Center are unique. They hold OECI membership and are affiliated with Johns Hopkins. This gives patients access to the same treatment protocols. The world’s leading cancer hospitals use them. This connection means patients' CyberKnife plans follow high international standards.
Patient Consensus: Patients in Turkey report significant mass reduction in benign tumours. This reduction occurs within months of the session. They value the 45-minute outpatient sessions. They can recover in Istanbul without the distress of a hospital stay.
What are the benefits of CyberKnife compared to traditional brain surgery?
CyberKnife offers a non-invasive alternative to traditional brain surgery. It uses robotic radiosurgery to treat tumours with sub-millimetre precision. It eliminates the need for incisions, general anaesthesia, or metal head frames. This means patients can drive themselves home immediately after treatments in Istanbul or Antalya.
- Non-invasive delivery: Treats tumours with robotic precision without surgical incisions or skull pins.
- Healthy tissue preservation: Spares surrounding brain tissue from high radiation doses using sub-millimetre accuracy.
- Outpatient recovery: Requires zero hospital stays, allowing an immediate return to normal daily activities.
- Inoperable tumour access: Reaches difficult areas like the brainstem that traditional surgery often cannot safely access.
- Reduced procedural risk: Avoids surgical complications like infection, post-operative bleeding, or risks from anaesthesia.
Bookimed Expert Insight: CyberKnife takes five sessions over two weeks. However, it resolves one major patient fear associated with Gamma Knife. It does not require a rigid metal frame screwed into the skull. Bookimed data shows Turkish centres like Anadolu Medical Center pair this comfort with high-level expertise. Specialists there often hold Stanford fellowships and JCI accreditation.
Patient Consensus: Patients in Turkey value how CyberKnife maintains their quality of life with minimal fatigue. They report significant tumour shrinkage without the distress of head brackets. They also avoid the long recovery periods required after traditional theatre procedures.
How does CyberKnife treatment for brain tumours work?
CyberKnife for brain tumours uses high-dose radiation delivered by a robotic arm with sub-millimetre precision. This non-invasive system tracks tumour movement in real-time. This lets specialists at Turkish centres like Anadolu Medical Center target malignant or benign masses. The treatment also spares healthy brain tissue.
- Frameless delivery: Patients wear a custom mask instead of a bolted head frame.
- Robotic precision: A robotic arm delivers beams from hundreds of angles for accuracy.
- Real-time tracking: Artificial intelligence adjusts radiation beams instantly if the patient moves or breathes.
- Outpatient sessions: Treatment takes 15–45 minutes and typically requires only 1–5 sessions.
Bookimed Expert Insight: Turkish oncology centres often provide more versatility for complex cases than standard facilities. Clinics like Medipol Mega University Hospital host both CyberKnife and Gamma Knife systems. This allows multi-disciplinary teams to select the specific radiation technology. They can pick the one that best fits a tumour’s size and location.
Patient Consensus: Patients in Turkey find the procedure remarkably easy. This is because they remain awake and can often drive themselves home. Many report feeling only mild fatigue during treatment. They can successfully target multiple brain spots in a single 45-minute session.
How long does a CyberKnife treatment session for a brain tumour in Turkey take?
A CyberKnife brain tumour session in Turkey usually takes between 30 and 90 minutes. The exact time depends on the tumour size and location. Most patients require 1–5 sessions delivered over consecutive days. This non-invasive robotic radiosurgery requires no anaesthesia or hospital stay.
- Session duration: Individual treatments typically last 30–60 minutes but complex cases take longer.
- Total appointments: Patients should allow 2 hours total per visit for precise positioning.
- No hospitalisation: The procedure is outpatient, so patients return to their hotel immediately.
- Success rates: Specialised centres such as Memorial Sisli maintain a 90% success rate.
Bookimed Expert Insight: CyberKnife in Turkey offers a significant comfort advantage over Gamma Knife for brain tumours. Professors such as Dr Banu Atalar at Anadolu Medical Center use CyberKnife. This avoids the painful fixed head frames required by other systems. This flexibility allows for shorter, more comfortable sessions that spare more healthy tissue.
Patient Consensus: During 30–90 minute sessions, the lack of a head frame reduces distress for patients in Turkey. Patients describe the experience as smooth and professional. Helpful staff assist throughout the process.
When will the brain tumour disappear after CyberKnife treatment?
Brain tumours do not disappear immediately after CyberKnife treatment. Success is typically confirmed via MRI within 12 to 24 months. While metastatic tumours may shrink in months, benign lesions often take 2 years to stabilise. The goal is long-term control rather than instant removal.
- Response timeline: Metastatic tumours often show visible results within a few months of treatment.
- Benign tumours: Shrinkage or stability usually occurs over 18 months to 2 years.
- Initial swelling: Temporary swelling often occurs during the first 12 months after radiation delivery.
- Monitoring schedule: Specialists perform follow-up MRI scans at 6, 12, and 24 months post-treatment.
- Success definition: Doctors consider stable tumour size a success, often achieving 85% to 95% control.
Bookimed Expert Insight: Data from Turkish clinics like Anadolu Medical Center shows patients typically return to work immediately. Unlike surgery, CyberKnife avoids fatigue and hair loss. For aggressive cases like glioblastoma, specialists may combine CyberKnife with Avastin to improve remission rates.
Patient Consensus: Turkish medical teams focus on long-term stability where the tumour stops growing. Patients report a painless experience and note that central necrosis often proves the treatment worked.






















